Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia--a review.
about
Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in ratsSuccessful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhageDiffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patientsThe role of initial radiologic and clinical manifestations in predicting the prognosis for pneumonia caused by H1N1 influenza virus.Outcome of pandemic H1N1 pneumonia: clinical and radiological findings for severity assessment.Oxidized phospholipids reduce ventilator-induced vascular leak and inflammation in vivoComplete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation.Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia.Induction of cellular antioxidant defense by amifostine improves ventilator-induced lung injury.Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study.Anti-human tissue factor antibody ameliorated intestinal ischemia reperfusion-induced acute lung injury in human tissue factor knock-in mice.Ventilator-associated pneumonia: problems with diagnosis and therapyRole of diabetes in the development of acute respiratory distress syndrome.Association of TNF-alpha gene with spontaneous deep intracerebral hemorrhage in the Taiwan population: a case control studyLung endothelial barrier protection by iloprost in the 2-hit models of ventilator-induced lung injury (VILI) involves inhibition of Rho signaling.Influenza Virus H1N1 inhibition by serine protease inhibitor (serpin) antithrombin IIISildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDSFailure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis.Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort study.Nebulized fibrinolytic agents improve pulmonary fibrinolysis but not inflammation in rat models of direct and indirect acute lung injury.Transcriptional events during the recovery from MRSA lung infection: a mouse pneumonia modelLow molecular weight heparin prevents CLP-induced acute lung injury in rats by anti-inflammatory coagulationRecombinant human activated protein C in the treatment of acute respiratory distress syndrome: a randomized clinical trial.Blood transfusion during cardiac surgery is associated with inflammation and coagulation in the lung: a case control study.Anti-inflammatory and anticoagulative effects of paeonol on LPS-induced acute lung injury in rats.α-Enolase Causes Proinflammatory Activation of Pulmonary Microvascular Endothelial Cells and Primes Neutrophils Through Plasmin Activation of Protease-Activated Receptor 2.Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort studyCoagulopathy as a prognostic factor of acute lung injury in childrenStaphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis.Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndromeThe 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis.Cell wounding and repair in ventilator injured lungs.Inhalation of activated protein C: A possible new adjunctive intervention in acute respiratory distress syndrome.Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment.Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.Rap1 mediates protective effects of iloprost against ventilator-induced lung injury.Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigationsEfficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis.Anticoagulant therapy in acute lung injury: a useful tool without proper operating instruction?Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage.
P2860
Q21092892-E3EF84A2-8D22-48CC-A9B2-069820810E33Q21195043-93D6340C-D940-4BDD-B508-F0B061A7BBCFQ26749256-9C8139AD-263F-439A-A7C2-272CFA518E60Q30364143-D9F4CF76-5E50-4A27-9E42-131210B2BCC4Q30404367-3D1F2518-5DE4-447B-8F79-42CB61E2FC7DQ30441814-AA8DB171-BBBD-48A0-BFEF-821B03BE91EAQ30442280-E2FFBB1B-9484-4EED-84DE-6146D87DFF37Q30484594-E4888495-9A93-43AD-998C-D231744B7901Q30539903-38D006A0-2F86-4ECC-B21D-8A467CE055A3Q30951627-99549A80-33EC-4A1C-A28C-04F9B277F93AQ33317288-8F94837D-38DD-4D39-A452-B88C2CF16E9DQ33373424-C22F03B3-A7AE-4FEB-98C7-3C2D72EB4BE8Q33555078-DF039B5C-9F1F-436E-BA0E-D632052541C1Q33599444-0A652C5D-0784-44B0-9371-595523D9D81DQ33621771-45438047-2324-4345-B267-EE10F3064395Q33679314-436CE82A-0154-4CB6-8395-C85C890F5360Q33773262-4486FE1D-18EF-477F-A5CC-202640C72601Q33994030-B0157700-3BE6-4FF0-99E4-7CA7AD3B5D54Q34380703-79191183-B826-4770-915A-A0254B3F7B40Q34585962-81D47A9D-8179-4F15-B03C-C2E8024B2D7FQ34925134-418F835C-AE3A-453A-87BF-BCA88F3547E6Q35099710-E3D65026-2510-46C4-8085-8CAC8B5B14E7Q35121618-61D4BC78-0E25-426E-909E-6903A7464459Q35567004-AB9DEB08-B347-4764-8976-F649EF57905BQ35794087-BD18D9B2-D112-4517-826A-790F21D76FD6Q35862784-FE2303D9-5494-4A8C-A487-8FD9A5737A8FQ36073215-10B5D2A8-68EF-452E-AC19-F468D574AC66Q36472995-CEEF863B-77F2-4DF7-B2CE-D96ABDE3868DQ36631071-03A6CA07-3660-4CBC-867F-DFDD2137E316Q36835719-FEF110D2-3124-464A-A62E-982FCF009222Q36997866-C66824C1-C825-4B19-A96D-D6C418F41FCEQ37220652-1B90E526-1A89-4750-AE2A-AE2A3673AD57Q37290460-FC1A281F-8117-4ED1-9343-CF85265A7E71Q37360290-43577D60-5CA5-4B69-895F-6EB490C1A6CCQ37443132-3522955D-0B03-4849-98F5-1594BAA9C80EQ37475086-83F707B9-6208-42C8-B2BC-BCC3A1476E15Q38006576-B12D4720-76C0-4F5B-B512-AE8E0B69D0CCQ39496476-B410A432-1F91-47C4-A295-3B7323C4F40FQ40040333-B1227B19-C732-466F-96D4-83626673237DQ40979900-BB0D0B63-59E7-4CF4-9F8E-64B564FA7222
P2860
Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia--a review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pulmonary coagulopathy as a ne ...... injury or pneumonia--a review.
@ast
Pulmonary coagulopathy as a ne ...... injury or pneumonia--a review.
@en
type
label
Pulmonary coagulopathy as a ne ...... injury or pneumonia--a review.
@ast
Pulmonary coagulopathy as a ne ...... injury or pneumonia--a review.
@en
prefLabel
Pulmonary coagulopathy as a ne ...... injury or pneumonia--a review.
@ast
Pulmonary coagulopathy as a ne ...... injury or pneumonia--a review.
@en
P1476
Pulmonary coagulopathy as a ne ...... injury or pneumonia--a review.
@en
P2093
Haibo Zhang
Jack J Haitsma
P304
P356
10.1097/01.CCM.0000202136.91651.34
P407
P577
2006-03-01T00:00:00Z